The growth of co-transformed cells in the peritoneal cavity alters their cellular gene expression to mirror that of PEL biopsies. حسب Mitchell Hayes (5334887)

Co-infected cells express both KSHV and EBV genes <i>in vitro</i> necessary for their survival and growth. حسب Mitchell Hayes (5334887)

Loss of RBM-26 causes mitochondria dysfunction in PLM. حسب Tamjid A. Chowdhury (14149846)

RBM-26 is expressed in the PLM and functions within neurons to protect against axon degeneration and prevent axon overlap defects. حسب Tamjid A. Chowdhury (14149846)

Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. حسب Tamjid A. Chowdhury (14149846)

Summary of Biomarker Expression in Benign Samples. The STT and LTT groups exhibit significant changes in biomarker expression compared to the nontreatment group, measured on a two-... حسب Jinho Lee (587173)

الموضوعات:

Proportion of stillbirths in Stockholm among twin and singleton pregnancies. حسب Matilda Varli Hjärne (22766125)

Loss of RBM-26 function causes a reduction in the density of mitochondria in the PLM axon. حسب Tamjid A. Chowdhury (14149846)

Summary of subgroup analysis results. حسب Junyin Pan (20700411)

الموضوعات:

Original study data. حسب Junyin Pan (20700411)

الموضوعات:

S2 File - حسب Junyin Pan (20700411)

الموضوعات:

HBV RNaseH inhibitors effects on capsid accumulation occur independent of HBV DNA synthesis. حسب Daniel P. Bradley (10306893)

Co-transformed cells grow preferentially as tumors in peritoneal cavities. حسب Mitchell Hayes (5334887)

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. حسب Tamjid A. Chowdhury (14149846)

Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors. حسب Daniel P. Bradley (10306893)

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. حسب Daniel P. Bradley (10306893)

1466 inhibits capsid accumulation independent of HBV replication. حسب Daniel P. Bradley (10306893)

Differences among the classes of CAMs. حسب Daniel P. Bradley (10306893)

"…Some <i>N</i>-hydroxypyridinedione (HPD) HBV RNaseH inhibitors significantly reduced accumulation of capsids in HBV-replicating cells. …"

Changes in the genotypes of <i>NLRP1</i>, <i>NLRP3</i>, and <i>NLRP4</i>. حسب Hao Deng (409186)

الموضوعات:

Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. حسب Hao Deng (409186)

الموضوعات: